121 filings
ARS
2023 FY
ORIC
ORIC Pharmaceuticals Inc
24 Apr 24
Annual report to shareholders
4:15pm
DEFA14A
ORIC
ORIC Pharmaceuticals Inc
24 Apr 24
Additional proxy soliciting materials
4:10pm
DEF 14A
ORIC
ORIC Pharmaceuticals Inc
Definitive proxy
24 Apr 24
4:06pm
S-8
ORIC
ORIC Pharmaceuticals Inc
29 Mar 24
Registration of securities for employees
4:47pm
8-K
ORIC
ORIC Pharmaceuticals Inc
29 Mar 24
Departure of Directors or Certain Officers
4:15pm
S-3ASR
noxv39qtju8ea67i7mj7
11 Mar 24
Automatic shelf registration
5:28pm
8-K
2g7ejlcx3yef
11 Mar 24
ORIC Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results and Operational Updates
4:10pm
EFFECT
b8mk8bikpxirtddri9k5
5 Feb 24
Notice of effectiveness
12:15am
UPLOAD
izejv0ocb
31 Jan 24
Letter from SEC
12:00am
CORRESP
mt2yiz3wvig
31 Jan 24
Correspondence with SEC
12:00am
D
maeuj
30 Jan 24
$125.00 mm in equity, sold $125.00 mm, 10 investors
12:12pm
8-K
n86erpofjduqi atzuj
22 Jan 24
ORIC Pharmaceuticals Announces $125 Million Private Placement Financing
9:01am
8-K
iphxonz8 p5
9 Jan 24
Results of Operations and Financial Condition
9:00am
EFFECT
jol4zdw
29 Dec 23
Notice of effectiveness
12:15am
CORRESP
2d2foyi82f twv8
26 Dec 23
Correspondence with SEC
12:00am
UPLOAD
k67rb okal
22 Dec 23
Letter from SEC
12:00am
S-3
89yzof2yuc 00d
15 Dec 23
Shelf registration
4:32pm
8-K
sdcb02g1e88l
11 Dec 23
Other Events
4:05pm